speb/financial-data huggingface dataset:
CME cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 1238100000.00
CME cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: 22900000.00
CME income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: 1389300000.00
CME balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: 59400000.00
CME income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 28200000.00
CME balance_sheet (quarterly, 2026-03-31) — Goodwill: 10506000000.00
CME balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 30232100000.00
CME balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 945000000.00
CME balance_sheet (quarterly, 2026-03-31) — Gross PPE: 1383700000.00
CME income_statement (quarterly, 2026-03-31) — Gross Profit: 1657100000.00
CME cash_flow (quarterly, 2026-03-31) — Income Tax Paid Supplemental Data: 42700000.00
CME income_statement (quarterly, 2026-03-31) — Interest Expense: 43600000.00
CME income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 43600000.00
CME cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 46300000.00
CME balance_sheet (quarterly, 2026-03-31) — Invested Capital: 30041400000.00
CME cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -23000000.00
CME cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 0.00
CME balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 3423200000.00
CME balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 3423200000.00
CME cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 0.00
CME cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: 0.00
CME cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: -1500000.00
CME cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -538700000.00
CME balance_sheet (quarterly, 2026-03-31) — Net Debt: 1032000000.00
CME income_statement (quarterly, 2026-03-31) — Net Income: 1154300000.00
CME income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 1168000000.00
CME income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 1154300000.00
CME income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 1154300000.00
CME income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 1154300000.00
CME cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 1154300000.00
CME income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 1154300000.00
CME income_statement (quarterly, 2026-03-31) — Net Interest Income: -43600000.00
CME cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: 300000.00
CME cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: 0.00
CME cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: 0.00
CME income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -43600000.00
CME cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: 5352800000.00
CME balance_sheet (quarterly, 2026-03-31) — Net PPE: 355400000.00
CME cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -21800000.00
CME balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: -3613900000.00
CME balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 5221100000.00
CME balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 5221100000.00
CME income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 248500000.00
CME income_statement (quarterly, 2026-03-31) — Normalized Income: 92874800.00
CME cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 1259900000.00
CME cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 22900000.00
CME income_statement (quarterly, 2026-03-31) — Operating Income: 1309700000.00
CME income_statement (quarterly, 2026-03-31) — Operating Revenue: 1766700000.00
CME balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 361793138.00
CME balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 508600000.00
CME balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 165922400000.00
CME balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: 59400000.00
CME income_statement (quarterly, 2026-03-31) — Other Gand A: 28200000.00
CME income_statement (quarterly, 2026-03-31) — Other Income Expense: 244800000.00
CME balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 19726100000.00
CME cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: -11100000.00
CME balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 2404800000.00
CME balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 733200000.00
CME income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: -1246900000.00
CME income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 235900000.00
CME balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 124200000.00
CME income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
CME balance_sheet (quarterly, 2026-03-31) — Payables: 75400000.00
CME balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 75400000.00
CME balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
CME income_statement (quarterly, 2026-03-31) — Preferred Stock Dividends: -13700000.00
CME income_statement (quarterly, 2026-03-31) — Pretax Income: 1510900000.00
CME cash_flow (quarterly, 2026-03-31) — Purchase Of Business: -1500000.00
CME cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -800000.00
CME cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -21800000.00
CME balance_sheet (quarterly, 2026-03-31) — Receivables: 935500000.00
CME income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 223000000.00
CME income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 83300000.00
CME cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: 0.00
CME cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -538700000.00
CME balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 165041700000.00
CME balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 4884600000.00
CME cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 1100000.00
CME income_statement (quarterly, 2026-03-31) — Selling General And Administration: 28200000.00
CME balance_sheet (quarterly, 2026-03-31) — Share Issued: 361793138.00
CME cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 21800000.00
CME balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 26618200000.00
CME balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: -3613900000.00
CME income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 327874800.00
CME income_statement (quarterly, 2026-03-31) — Tax Provision: 356600000.00
CME income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.24
CME balance_sheet (quarterly, 2026-03-31) — Total Assets: 201993500000.00
CME balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 30041400000.00
CME balance_sheet (quarterly, 2026-03-31) — Total Debt: 3423200000.00
CME balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 26618200000.00
CME income_statement (quarterly, 2026-03-31) — Total Expenses: 570400000.00
CME balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 175375300000.00
CME balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 32992300000.00
CME balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 9377500000.00
CME income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 1309700000.00
CME income_statement (quarterly, 2026-03-31) — Total Unusual Items: 1389300000.00
CME income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 1389300000.00
CME balance_sheet (quarterly, 2026-03-31) — Working Capital: 3003400000.00
CME income_statement (quarterly, 2026-06-30) — Basic Average Shares: 360684000.00
CME income_statement (quarterly, 2026-06-30) — Basic EPS: 2.89
CME income_statement (quarterly, 2026-06-30) — Diluted Average Shares: 361282000.00
CME income_statement (quarterly, 2026-06-30) — Diluted EPS: 2.88
CMET.L income_statement (annual, 2022-03-31) — +Operating Expense: 1718624.00
CMET.L income_statement (annual, 2022-03-31) — +Total Revenue: 0.00
CMET.L balance_sheet (annual, 2022-03-31) — Accounts Payable: 67659.00
CMET.L balance_sheet (annual, 2022-03-31) — Accounts Receivable: 14843.00
CMET.L balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -52929.00
CMET.L balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 50196676.00
CMET.L income_statement (annual, 2022-03-31) — Basic Average Shares: 531043035.00
CMET.L income_statement (annual, 2022-03-31) — Basic EPS: 0.00
CMET.L cash_flow (annual, 2022-03-31) — Beginning Cash Position: 1797319.00
CMET.L cash_flow (annual, 2022-03-31) — Capital Expenditure: -496578.00
CMET.L cash_flow (annual, 2022-03-31) — Capital Expenditure Reported: -490000.00
CMET.L balance_sheet (annual, 2022-03-31) — Capital Stock: 510403.00
CMET.L balance_sheet (annual, 2022-03-31) — Cash And Cash Equivalents: 1775754.00
CMET.L balance_sheet (annual, 2022-03-31) — Cash Cash Equivalents And Short Term Investments: 1775754.00
CMET.L balance_sheet (annual, 2022-03-31) — Cash Financial: 1775754.00
CMET.L cash_flow (annual, 2022-03-31) — Change In Payable: 23232.00
CMET.L cash_flow (annual, 2022-03-31) — Change In Receivables: 73097.00
CMET.L cash_flow (annual, 2022-03-31) — Change In Working Capital: 96329.00
CMET.L cash_flow (annual, 2022-03-31) — Changes In Cash: 44256.00
CMET.L balance_sheet (annual, 2022-03-31) — Common Stock: 510403.00
CMET.L balance_sheet (annual, 2022-03-31) — Common Stock Equity: 5070465.00
CMET.L cash_flow (annual, 2022-03-31) — Common Stock Issuance: 1641756.00
CMET.L income_statement (annual, 2022-03-31) — Cost Of Revenue: 8832.00
CMET.L balance_sheet (annual, 2022-03-31) — Current Assets: 1811914.00
CMET.L balance_sheet (annual, 2022-03-31) — Current Liabilities: 723926.00
CMET.L cash_flow (annual, 2022-03-31) — Depreciation: 8832.00
CMET.L cash_flow (annual, 2022-03-31) — Depreciation And Amortization: 8832.00
CMET.L income_statement (annual, 2022-03-31) — Depreciation And Amortization In Income Statement: 8832.00
CMET.L income_statement (annual, 2022-03-31) — Depreciation Income Statement: 8832.00
CMET.L income_statement (annual, 2022-03-31) — Diluted Average Shares: 531043035.00
CMET.L income_statement (annual, 2022-03-31) — Diluted EPS: 0.00
CMET.L income_statement (annual, 2022-03-31) — Diluted NI Availto Com Stockholders: -1914233.00
CMET.L income_statement (annual, 2022-03-31) — EBIT: -1727456.00
CMET.L income_statement (annual, 2022-03-31) — EBITDA: -1718624.00
CMET.L cash_flow (annual, 2022-03-31) — Effect Of Exchange Rate Changes: -65821.00
CMET.L cash_flow (annual, 2022-03-31) — End Cash Position: 1775754.00
CMET.L cash_flow (annual, 2022-03-31) — Financing Cash Flow: 1520733.00
CMET.L cash_flow (annual, 2022-03-31) — Free Cash Flow: -1481153.00
CMET.L income_statement (annual, 2022-03-31) — General And Administrative Expense: 628601.00
CMET.L balance_sheet (annual, 2022-03-31) — Gross PPE: 4637680.00
CMET.L income_statement (annual, 2022-03-31) — Gross Profit: -8832.00
CMET.L income_statement (annual, 2022-03-31) — Interest Income: 470.00
CMET.L income_statement (annual, 2022-03-31) — Interest Income Non Operating: 470.00
CMET.L cash_flow (annual, 2022-03-31) — Interest Paid Cff: 0.00
CMET.L cash_flow (annual, 2022-03-31) — Interest Received Cfi: 388.00
CMET.L balance_sheet (annual, 2022-03-31) — Invested Capital: 5070465.00
CMET.L cash_flow (annual, 2022-03-31) — Investing Cash Flow: -491902.00
CMET.L balance_sheet (annual, 2022-03-31) — Investmentsin Subsidiariesat Cost: 0.00
CMET.L cash_flow (annual, 2022-03-31) — Issuance Of Capital Stock: 1641756.00
CMET.L cash_flow (annual, 2022-03-31) — Issuance Of Debt: 0.00
CMET.L cash_flow (annual, 2022-03-31) — Long Term Debt Issuance: 0.00
CMET.L cash_flow (annual, 2022-03-31) — Long Term Debt Payments: 0.00
CMET.L balance_sheet (annual, 2022-03-31) — Long Term Equity Investment: 0.00
CMET.L balance_sheet (annual, 2022-03-31) — Minority Interest: 0.00
CMET.L cash_flow (annual, 2022-03-31) — Net Business Purchase And Sale: 0.00
CMET.L cash_flow (annual, 2022-03-31) — Net Common Stock Issuance: 1641756.00
CMET.L cash_flow (annual, 2022-03-31) — Net Foreign Currency Exchange Gain Loss: 104043.00
CMET.L income_statement (annual, 2022-03-31) — Net Income: -1914233.00
CMET.L income_statement (annual, 2022-03-31) — Net Income Common Stockholders: -1914233.00
CMET.L income_statement (annual, 2022-03-31) — Net Income Continuous Operations: -1914233.00
CMET.L income_statement (annual, 2022-03-31) — Net Income From Continuing And Discontinued Operation: -1914233.00
CMET.L income_statement (annual, 2022-03-31) — Net Income From Continuing Operation Net Minority Interest: -1914233.00
CMET.L cash_flow (annual, 2022-03-31) — Net Income From Continuing Operations: -1914233.00
CMET.L income_statement (annual, 2022-03-31) — Net Income Including Noncontrolling Interests: -1914233.00
CMET.L income_statement (annual, 2022-03-31) — Net Interest Income: 470.00
CMET.L cash_flow (annual, 2022-03-31) — Net Issuance Payments Of Debt: 0.00
CMET.L cash_flow (annual, 2022-03-31) — Net Long Term Debt Issuance: 0.00
CMET.L income_statement (annual, 2022-03-31) — Net Non Operating Interest Income Expense: 470.00
CMET.L balance_sheet (annual, 2022-03-31) — Net PPE: 4584751.00
CMET.L cash_flow (annual, 2022-03-31) — Net PPE Purchase And Sale: -492290.00
CMET.L balance_sheet (annual, 2022-03-31) — Net Tangible Assets: 5070465.00
CMET.L income_statement (annual, 2022-03-31) — Normalized EBITDA: -1686128.00
CMET.L income_statement (annual, 2022-03-31) — Normalized Income: -1881737.00
CMET.L cash_flow (annual, 2022-03-31) — Operating Cash Flow: -984575.00
CMET.L income_statement (annual, 2022-03-31) — Operating Income: -1727456.00
CMET.L income_statement (annual, 2022-03-31) — Operating Revenue: 0.00
CMET.L balance_sheet (annual, 2022-03-31) — Ordinary Shares Number: 189103432.00
CMET.L balance_sheet (annual, 2022-03-31) — Other Current Liabilities: 594372.00
CMET.L balance_sheet (annual, 2022-03-31) — Other Equity Interest: 11691717.00
CMET.L cash_flow (annual, 2022-03-31) — Other Non Cash Items: -388.00
CMET.L balance_sheet (annual, 2022-03-31) — Other Non Current Liabilities: 600002.00
CMET.L income_statement (annual, 2022-03-31) — Otherunder Preferred Stock Dividend: 0.00
CMET.L balance_sheet (annual, 2022-03-31) — Payables: 67659.00
CMET.L balance_sheet (annual, 2022-03-31) — Prepaid Assets: 13481.00
CMET.L income_statement (annual, 2022-03-31) — Pretax Income: -1914233.00
CMET.L balance_sheet (annual, 2022-03-31) — Properties: 4556210.00
CMET.L cash_flow (annual, 2022-03-31) — Purchase Of Business: 0.00
CMET.L cash_flow (annual, 2022-03-31) — Purchase Of PPE: -496578.00
CMET.L income_statement (annual, 2022-03-31) — Reconciled Cost Of Revenue: 8832.00
CMET.L income_statement (annual, 2022-03-31) — Reconciled Depreciation: 8832.00
CMET.L cash_flow (annual, 2022-03-31) — Repayment Of Debt: 0.00
CMET.L income_statement (annual, 2022-03-31) — Restructuring And Mergern Acquisition: 32496.00
CMET.L balance_sheet (annual, 2022-03-31) — Retained Earnings: -14431567.00
CMET.L cash_flow (annual, 2022-03-31) — Sale Of PPE: 4288.00
CMET.L income_statement (annual, 2022-03-31) — Selling General And Administration: 628601.00
CMET.L balance_sheet (annual, 2022-03-31) — Share Issued: 189103432.00
CMET.L income_statement (annual, 2022-03-31) — Special Income Charges: -32496.00
CMET.L cash_flow (annual, 2022-03-31) — Stock Based Compensation: 720842.00
CMET.L balance_sheet (annual, 2022-03-31) — Stockholders Equity: 5070465.00
CMET.L balance_sheet (annual, 2022-03-31) — Tangible Book Value: 5070465.00
CMET.L income_statement (annual, 2022-03-31) — Tax Effect Of Unusual Items: 0.00
CMET.L income_statement (annual, 2022-03-31) — Tax Provision: 0.00
CMET.L income_statement (annual, 2022-03-31) — Tax Rate For Calcs: 0.00
CMET.L balance_sheet (annual, 2022-03-31) — Taxes Receivable: 7836.00
CMET.L balance_sheet (annual, 2022-03-31) — Total Assets: 6396665.00
CMET.L balance_sheet (annual, 2022-03-31) — Total Capitalization: 5070465.00
CMET.L balance_sheet (annual, 2022-03-31) — Total Equity Gross Minority Interest: 5070465.00
CMET.L income_statement (annual, 2022-03-31) — Total Expenses: 1727456.00
CMET.L balance_sheet (annual, 2022-03-31) — Total Liabilities Net Minority Interest: 1326200.00
CMET.L balance_sheet (annual, 2022-03-31) — Total Non Current Assets: 4584751.00
CMET.L balance_sheet (annual, 2022-03-31) — Total Non Current Liabilities Net Minority Interest: 602274.00
CMET.L income_statement (annual, 2022-03-31) — Total Operating Income As Reported: -1914703.00
CMET.L balance_sheet (annual, 2022-03-31) — Total Tax Payable: 0.00
CMET.L income_statement (annual, 2022-03-31) — Total Unusual Items: -32496.00
CMET.L income_statement (annual, 2022-03-31) — Total Unusual Items Excluding Goodwill: -32496.00
CMET.L balance_sheet (annual, 2022-03-31) — Tradeand Other Payables Non Current: 2272.00
CMET.L balance_sheet (annual, 2022-03-31) — Working Capital: 1087988.00
CMET.L income_statement (annual, 2023-03-31) — +Operating Expense: 912975.00
CMET.L income_statement (annual, 2023-03-31) — +Total Revenue: 0.00
CMET.L balance_sheet (annual, 2023-03-31) — Accounts Payable: 90191.00
CMET.L balance_sheet (annual, 2023-03-31) — Accounts Receivable: 0.00
CMET.L balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -53715.00
CMET.L balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 50196676.00
CMET.L income_statement (annual, 2023-03-31) — Basic Average Shares: 545380934.00
CMET.L income_statement (annual, 2023-03-31) — Basic EPS: 0.00
CMET.L cash_flow (annual, 2023-03-31) — Beginning Cash Position: 1775754.00
CMET.L cash_flow (annual, 2023-03-31) — Capital Expenditure: -294856.00
CMET.L balance_sheet (annual, 2023-03-31) — Capital Stock: 510403.00
CMET.L balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 213625.00
CMET.L balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 213625.00
CMET.L balance_sheet (annual, 2023-03-31) — Cash Financial: 213625.00
CMET.L cash_flow (annual, 2023-03-31) — Change In Payable: 115885.00
CMET.L cash_flow (annual, 2023-03-31) — Change In Receivables: -5349.00
CMET.L cash_flow (annual, 2023-03-31) — Change In Working Capital: 110536.00
CMET.L cash_flow (annual, 2023-03-31) — Changes In Cash: -1456041.00
CMET.L balance_sheet (annual, 2023-03-31) — Common Stock: 510403.00
CMET.L balance_sheet (annual, 2023-03-31) — Common Stock Equity: 3520542.00
CMET.L cash_flow (annual, 2023-03-31) — Common Stock Issuance: 0.00
CMET.L income_statement (annual, 2023-03-31) — Cost Of Revenue: 3208.00
CMET.L balance_sheet (annual, 2023-03-31) — Current Assets: 256230.00
CMET.L balance_sheet (annual, 2023-03-31) — Current Liabilities: 841891.00
CMET.L cash_flow (annual, 2023-03-31) — Depreciation: 3208.00
CMET.L cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 3208.00
CMET.L income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 3208.00
CMET.L income_statement (annual, 2023-03-31) — Depreciation Income Statement: 3208.00
CMET.L income_statement (annual, 2023-03-31) — Diluted Average Shares: 545380934.00
CMET.L income_statement (annual, 2023-03-31) — Diluted EPS: 0.00
CMET.L income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: -1138538.00
CMET.L income_statement (annual, 2023-03-31) — EBIT: -916183.00
CMET.L income_statement (annual, 2023-03-31) — EBITDA: -912975.00
CMET.L cash_flow (annual, 2023-03-31) — Effect Of Exchange Rate Changes: -103500.00
CMET.L cash_flow (annual, 2023-03-31) — End Cash Position: 216213.00
CMET.L cash_flow (annual, 2023-03-31) — Financing Cash Flow: 0.00
CMET.L cash_flow (annual, 2023-03-31) — Free Cash Flow: -1335607.00
CMET.L income_statement (annual, 2023-03-31) — General And Administrative Expense: 586967.00
CMET.L balance_sheet (annual, 2023-03-31) — Gross PPE: 4531117.00
CMET.L income_statement (annual, 2023-03-31) — Gross Profit: -3208.00
CMET.L income_statement (annual, 2023-03-31) — Interest Income: 4495.00
CMET.L income_statement (annual, 2023-03-31) — Interest Income Non Operating: 4495.00
CMET.L cash_flow (annual, 2023-03-31) — Interest Received Cfi: 4463.00
CMET.L balance_sheet (annual, 2023-03-31) — Invested Capital: 3520542.00
CMET.L cash_flow (annual, 2023-03-31) — Investing Cash Flow: -415290.00
CMET.L balance_sheet (annual, 2023-03-31) — Investmentsin Subsidiariesat Cost: 0.00
CMET.L cash_flow (annual, 2023-03-31) — Issuance Of Capital Stock: 0.00
CMET.L balance_sheet (annual, 2023-03-31) — Long Term Equity Investment: 0.00
CMET.L balance_sheet (annual, 2023-03-31) — Minority Interest: -103430.00
CMET.L cash_flow (annual, 2023-03-31) — Net Business Purchase And Sale: -124897.00
CMET.L cash_flow (annual, 2023-03-31) — Net Common Stock Issuance: 0.00
CMET.L cash_flow (annual, 2023-03-31) — Net Foreign Currency Exchange Gain Loss: -11494.00
CMET.L income_statement (annual, 2023-03-31) — Net Income: -1138538.00
CMET.L income_statement (annual, 2023-03-31) — Net Income Common Stockholders: -1138538.00
CMET.L income_statement (annual, 2023-03-31) — Net Income Continuous Operations: -1138538.00
CMET.L income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: -1138538.00
CMET.L income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: -1138538.00
CMET.L cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: -1138538.00
CMET.L income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: -1138538.00
CMET.L income_statement (annual, 2023-03-31) — Net Interest Income: 4495.00
CMET.L income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: 4495.00
CMET.L balance_sheet (annual, 2023-03-31) — Net PPE: 4477402.00
CMET.L cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -294856.00
CMET.L balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 3520542.00
CMET.L income_statement (annual, 2023-03-31) — Normalized EBITDA: -875022.00
CMET.L income_statement (annual, 2023-03-31) — Normalized Income: -1100585.00
CMET.L cash_flow (annual, 2023-03-31) — Operating Cash Flow: -1040751.00
CMET.L income_statement (annual, 2023-03-31) — Operating Income: -916183.00
CMET.L income_statement (annual, 2023-03-31) — Operating Revenue: 0.00
CMET.L balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 189103432.00
CMET.L balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 593750.00
CMET.L balance_sheet (annual, 2023-03-31) — Other Equity Interest: 11691717.00
CMET.L cash_flow (annual, 2023-03-31) — Other Non Cash Items: -4463.00
CMET.L balance_sheet (annual, 2023-03-31) — Other Non Current Liabilities: 600000.00
CMET.L income_statement (annual, 2023-03-31) — Other Operating Expenses: 10535.00
CMET.L balance_sheet (annual, 2023-03-31) — Other Receivables: 3662.00
CMET.L income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
CMET.L balance_sheet (annual, 2023-03-31) — Payables: 92403.00
CMET.L balance_sheet (annual, 2023-03-31) — Prepaid Assets: 10022.00
CMET.L income_statement (annual, 2023-03-31) — Pretax Income: -1138538.00
CMET.L balance_sheet (annual, 2023-03-31) — Properties: 4451811.00
CMET.L cash_flow (annual, 2023-03-31) — Purchase Of Business: -124897.00
CMET.L cash_flow (annual, 2023-03-31) — Purchase Of PPE: -294856.00
CMET.L income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 3208.00
CMET.L income_statement (annual, 2023-03-31) — Reconciled Depreciation: 3208.00
CMET.L balance_sheet (annual, 2023-03-31) — Restricted Cash: 2588.00
CMET.L income_statement (annual, 2023-03-31) — Restructuring And Mergern Acquisition: 37953.00
CMET.L balance_sheet (annual, 2023-03-31) — Retained Earnings: -15570928.00
CMET.L cash_flow (annual, 2023-03-31) — Sale Of PPE: 0.00
CMET.L income_statement (annual, 2023-03-31) — Selling General And Administration: 586967.00
CMET.L balance_sheet (annual, 2023-03-31) — Share Issued: 189103432.00
CMET.L income_statement (annual, 2023-03-31) — Special Income Charges: -37953.00
CMET.L cash_flow (annual, 2023-03-31) — Stock Based Compensation: 0.00
CMET.L balance_sheet (annual, 2023-03-31) — Stockholders Equity: 3520542.00
CMET.L balance_sheet (annual, 2023-03-31) — Tangible Book Value: 3520542.00
CMET.L income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: 0.00
CMET.L income_statement (annual, 2023-03-31) — Tax Provision: 0.00
CMET.L income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.00
CMET.L balance_sheet (annual, 2023-03-31) — Taxes Receivable: 26333.00
CMET.L balance_sheet (annual, 2023-03-31) — Total Assets: 4859003.00
CMET.L balance_sheet (annual, 2023-03-31) — Total Capitalization: 3520542.00
CMET.L balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 3417112.00
CMET.L income_statement (annual, 2023-03-31) — Total Expenses: 916183.00
CMET.L balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 1441891.00
CMET.L balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 4602773.00
CMET.L balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 600000.00
CMET.L income_statement (annual, 2023-03-31) — Total Operating Income As Reported: -1143033.00
CMET.L balance_sheet (annual, 2023-03-31) — Total Tax Payable: 2212.00
CMET.L income_statement (annual, 2023-03-31) — Total Unusual Items: -37953.00
CMET.L income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: -37953.00
CMET.L balance_sheet (annual, 2023-03-31) — Working Capital: -585661.00
CMET.L income_statement (annual, 2024-03-31) — +Operating Expense: 780025.00
CMET.L income_statement (annual, 2024-03-31) — +Total Revenue: 0.00
CMET.L balance_sheet (annual, 2024-03-31) — Accounts Payable: 156747.00
CMET.L balance_sheet (annual, 2024-03-31) — Accounts Receivable: 0.00
CMET.L balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -66416.00
CMET.L balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 56173341.00
CMET.L income_statement (annual, 2024-03-31) — Basic Average Shares: 622139698.00
CMET.L income_statement (annual, 2024-03-31) — Basic EPS: 0.00
CMET.L cash_flow (annual, 2024-03-31) — Beginning Cash Position: 216213.00
CMET.L cash_flow (annual, 2024-03-31) — Capital Expenditure: -438008.00
CMET.L balance_sheet (annual, 2024-03-31) — Capital Stock: 903344.00
CMET.L balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 3084014.00
CMET.L balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 3084014.00
CMET.L balance_sheet (annual, 2024-03-31) — Cash Financial: 3084014.00
CMET.L cash_flow (annual, 2024-03-31) — Change In Payable: 5749.00
CMET.L cash_flow (annual, 2024-03-31) — Change In Receivables: -9106.00
CMET.L cash_flow (annual, 2024-03-31) — Change In Working Capital: -3357.00
CMET.L cash_flow (annual, 2024-03-31) — Changes In Cash: 2866724.00
CMET.L balance_sheet (annual, 2024-03-31) — Common Stock: 903344.00
CMET.L balance_sheet (annual, 2024-03-31) — Common Stock Equity: 7254424.00
CMET.L cash_flow (annual, 2024-03-31) — Common Stock Issuance: 4304987.00
CMET.L income_statement (annual, 2024-03-31) — Cost Of Revenue: 4021.00
CMET.L balance_sheet (annual, 2024-03-31) — Current Assets: 3131966.00
CMET.L balance_sheet (annual, 2024-03-31) — Current Liabilities: 847637.00
CMET.L cash_flow (annual, 2024-03-31) — Depreciation: 4021.00
CMET.L cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 4021.00
CMET.L income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 4021.00
CMET.L income_statement (annual, 2024-03-31) — Depreciation Income Statement: 4021.00
CMET.L income_statement (annual, 2024-03-31) — Diluted Average Shares: 622139698.00
CMET.L income_statement (annual, 2024-03-31) — Diluted EPS: 0.00
CMET.L income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: -931577.00
CMET.L income_statement (annual, 2024-03-31) — EBIT: -784046.00
CMET.L income_statement (annual, 2024-03-31) — EBITDA: -780025.00
CMET.L cash_flow (annual, 2024-03-31) — Effect Of Exchange Rate Changes: 4392.00
CMET.L cash_flow (annual, 2024-03-31) — End Cash Position: 3087329.00
CMET.L cash_flow (annual, 2024-03-31) — Financing Cash Flow: 4180387.00
CMET.L cash_flow (annual, 2024-03-31) — Free Cash Flow: -1315459.00
CMET.L income_statement (annual, 2024-03-31) — General And Administrative Expense: 535045.00
CMET.L balance_sheet (annual, 2024-03-31) — Gross PPE: 88005.00
CMET.L income_statement (annual, 2024-03-31) — Gross Profit: -4021.00
CMET.L income_statement (annual, 2024-03-31) — Interest Income: 1480.00
CMET.L income_statement (annual, 2024-03-31) — Interest Income Non Operating: 1480.00
CMET.L cash_flow (annual, 2024-03-31) — Interest Received Cfi: 1355.00
CMET.L balance_sheet (annual, 2024-03-31) — Invested Capital: 7254424.00
CMET.L cash_flow (annual, 2024-03-31) — Investing Cash Flow: -436212.00
CMET.L balance_sheet (annual, 2024-03-31) — Investmentsin Subsidiariesat Cost: 0.00
CMET.L cash_flow (annual, 2024-03-31) — Issuance Of Capital Stock: 4304987.00
CMET.L balance_sheet (annual, 2024-03-31) — Long Term Equity Investment: 0.00
CMET.L balance_sheet (annual, 2024-03-31) — Minority Interest: -73890.00
CMET.L cash_flow (annual, 2024-03-31) — Net Business Purchase And Sale: 0.00
CMET.L cash_flow (annual, 2024-03-31) — Net Common Stock Issuance: 4304987.00
CMET.L cash_flow (annual, 2024-03-31) — Net Foreign Currency Exchange Gain Loss: -16153.00
CMET.L income_statement (annual, 2024-03-31) — Net Income: -931577.00
CMET.L income_statement (annual, 2024-03-31) — Net Income Common Stockholders: -931577.00
CMET.L income_statement (annual, 2024-03-31) — Net Income Continuous Operations: -931577.00
CMET.L income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: -931577.00
CMET.L income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: -931577.00
CMET.L cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: -931577.00
CMET.L income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: -931577.00
CMET.L income_statement (annual, 2024-03-31) — Net Interest Income: 1480.00
CMET.L income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: 1480.00
CMET.L balance_sheet (annual, 2024-03-31) — Net PPE: 5354060.00
CMET.L cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -437567.00
CMET.L balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 7254424.00
CMET.L income_statement (annual, 2024-03-31) — Normalized EBITDA: -761173.00
CMET.L income_statement (annual, 2024-03-31) — Normalized Income: -912725.00
CMET.L cash_flow (annual, 2024-03-31) — Operating Cash Flow: -877451.00
CMET.L income_statement (annual, 2024-03-31) — Operating Income: -784046.00
CMET.L income_statement (annual, 2024-03-31) — Operating Revenue: 0.00
CMET.L balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 344806209.00
CMET.L balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 593750.00
CMET.L balance_sheet (annual, 2024-03-31) — Other Equity Interest: 8123448.00
CMET.L cash_flow (annual, 2024-03-31) — Other Non Cash Items: -1355.00
CMET.L balance_sheet (annual, 2024-03-31) — Other Non Current Liabilities: 600000.00
CMET.L income_statement (annual, 2024-03-31) — Other Operating Expenses: 2142.00
CMET.L balance_sheet (annual, 2024-03-31) — Other Receivables: 1431.00
CMET.L income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
CMET.L balance_sheet (annual, 2024-03-31) — Payables: 162237.00
CMET.L balance_sheet (annual, 2024-03-31) — Prepaid Assets: 20439.00
CMET.L income_statement (annual, 2024-03-31) — Pretax Income: -931577.00
CMET.L balance_sheet (annual, 2024-03-31) — Properties: 5332471.00
CMET.L cash_flow (annual, 2024-03-31) — Purchase Of Business: 0.00
CMET.L cash_flow (annual, 2024-03-31) — Purchase Of PPE: -438008.00
CMET.L income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 4021.00
CMET.L income_statement (annual, 2024-03-31) — Reconciled Depreciation: 4021.00
CMET.L balance_sheet (annual, 2024-03-31) — Restricted Cash: 3315.00
CMET.L income_statement (annual, 2024-03-31) — Restructuring And Mergern Acquisition: 18852.00
CMET.L balance_sheet (annual, 2024-03-31) — Retained Earnings: -15052742.00
CMET.L cash_flow (annual, 2024-03-31) — Sale Of PPE: 441.00
CMET.L income_statement (annual, 2024-03-31) — Selling General And Administration: 535045.00
CMET.L balance_sheet (annual, 2024-03-31) — Share Issued: 344806209.00
CMET.L income_statement (annual, 2024-03-31) — Special Income Charges: -18852.00
CMET.L cash_flow (annual, 2024-03-31) — Stock Based Compensation: 70970.00
CMET.L balance_sheet (annual, 2024-03-31) — Stockholders Equity: 7254424.00
CMET.L balance_sheet (annual, 2024-03-31) — Tangible Book Value: 7254424.00
CMET.L income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: 0.00
CMET.L income_statement (annual, 2024-03-31) — Tax Provision: 0.00
CMET.L income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.00
CMET.L balance_sheet (annual, 2024-03-31) — Taxes Receivable: 22767.00
CMET.L balance_sheet (annual, 2024-03-31) — Total Assets: 8628171.00
CMET.L balance_sheet (annual, 2024-03-31) — Total Capitalization: 7254424.00
CMET.L balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 7180534.00
CMET.L income_statement (annual, 2024-03-31) — Total Expenses: 784046.00
CMET.L balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 1447637.00
CMET.L balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 5496205.00
CMET.L balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 600000.00
CMET.L income_statement (annual, 2024-03-31) — Total Operating Income As Reported: -933057.00
CMET.L balance_sheet (annual, 2024-03-31) — Total Tax Payable: 5490.00
CMET.L income_statement (annual, 2024-03-31) — Total Unusual Items: -18852.00
CMET.L income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: -18852.00
CMET.L balance_sheet (annual, 2024-03-31) — Working Capital: 2284329.00
CMET.L balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 790077.00
CMET.L balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 44625.00
CMET.L balance_sheet (quarterly, 2024-09-30) — Additional Paid In Capital: 54923341.00
CMET.L balance_sheet (quarterly, 2024-09-30) — Capital Stock: 6455344.00
CMET.L balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 2427569.00
CMET.L balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 2427569.00
CMET.L balance_sheet (quarterly, 2024-09-30) — Common Stock: 6455344.00
CMET.L balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: 7075454.00
CMET.L balance_sheet (quarterly, 2024-09-30) — Current Assets: 2472194.00
CMET.L balance_sheet (quarterly, 2024-09-30) — Current Liabilities: 790077.00
CMET.L balance_sheet (quarterly, 2024-09-30) — Invested Capital: 7075454.00
CMET.L balance_sheet (quarterly, 2024-09-30) — Minority Interest: -120143.00
CMET.L balance_sheet (quarterly, 2024-09-30) — Net PPE: 5729053.00
CMET.L balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 7075454.00
CMET.L balance_sheet (quarterly, 2024-09-30) — Other Equity Interest: 3218750.00
CMET.L balance_sheet (quarterly, 2024-09-30) — Payables: 790077.00
CMET.L balance_sheet (quarterly, 2024-09-30) — Retained Earnings: -15499523.00
CMET.L balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 7075454.00
CMET.L balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 7075454.00
CMET.L balance_sheet (quarterly, 2024-09-30) — Total Assets: 8345388.00
CMET.L balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 7075454.00
CMET.L balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 6955311.00
CMET.L balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 1390077.00
CMET.L balance_sheet (quarterly, 2024-09-30) — Total Non Current Assets: 5873194.00
CMET.L balance_sheet (quarterly, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 600000.00
CMET.L balance_sheet (quarterly, 2024-09-30) — Tradeand Other Payables Non Current: 600000.00
CMET.L balance_sheet (quarterly, 2024-09-30) — Working Capital: 1682117.00
CMET.L income_statement (annual, 2025-03-31) — +Operating Expense: 1007315.00
CMET.L income_statement (annual, 2025-03-31) — +Total Revenue: 0.00
CMET.L balance_sheet (annual, 2025-03-31) — Accounts Payable: 159901.00
CMET.L balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 159901.00
CMET.L balance_sheet (annual, 2025-03-31) — Accounts Receivable: 0.00
CMET.L balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 0.00
CMET.L balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -67658.00
CMET.L balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -67658.00
CMET.L balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 56186218.00
CMET.L balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 56186218.00
CMET.L income_statement (annual, 2025-03-31) — Basic Average Shares: 701083711.00
CMET.L income_statement (annual, 2025-03-31) — Basic EPS: 0.00
CMET.L cash_flow (annual, 2025-03-31) — Beginning Cash Position: 3087329.00
CMET.L cash_flow (annual, 2025-03-31) — Capital Expenditure: -658287.00
CMET.L balance_sheet (annual, 2025-03-31) — Capital Stock: 903344.00
CMET.L balance_sheet (quarterly, 2025-03-31) — Capital Stock: 903344.00
CMET.L balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 1347677.00
CMET.L balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 1347677.00
CMET.L balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 1347677.00
CMET.L balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 1347677.00
CMET.L balance_sheet (annual, 2025-03-31) — Cash Financial: 1347677.00
CMET.L balance_sheet (quarterly, 2025-03-31) — Cash Financial: 1347677.00
CMET.L cash_flow (annual, 2025-03-31) — Change In Payable: 36323.00
CMET.L cash_flow (annual, 2025-03-31) — Change In Receivables: -35400.00
CMET.L cash_flow (annual, 2025-03-31) — Change In Working Capital: 923.00
CMET.L cash_flow (annual, 2025-03-31) — Changes In Cash: -1813224.00
CMET.L balance_sheet (annual, 2025-03-31) — Common Stock: 903344.00
CMET.L balance_sheet (quarterly, 2025-03-31) — Common Stock: 903344.00
CMET.L balance_sheet (annual, 2025-03-31) — Common Stock Equity: 6291342.00
CMET.L balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 6291342.00
CMET.L cash_flow (annual, 2025-03-31) — Common Stock Issuance: 0.00
CMET.L income_statement (annual, 2025-03-31) — Cost Of Revenue: 3773.00
CMET.L balance_sheet (annual, 2025-03-31) — Current Assets: 1432225.00
CMET.L balance_sheet (quarterly, 2025-03-31) — Current Assets: 1432225.00
CMET.L balance_sheet (annual, 2025-03-31) — Current Liabilities: 883958.00
CMET.L balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 883958.00
CMET.L cash_flow (annual, 2025-03-31) — Depreciation: 6546.00
CMET.L cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 6546.00
CMET.L income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 3773.00
CMET.L income_statement (annual, 2025-03-31) — Depreciation Income Statement: 3773.00
CMET.L income_statement (annual, 2025-03-31) — Diluted Average Shares: 701083711.00
CMET.L income_statement (annual, 2025-03-31) — Diluted EPS: 0.00
CMET.L income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: -1140932.00
CMET.L income_statement (annual, 2025-03-31) — EBIT: -1011088.00
CMET.L income_statement (annual, 2025-03-31) — EBITDA: -1004542.00
CMET.L cash_flow (annual, 2025-03-31) — Effect Of Exchange Rate Changes: 77389.00
CMET.L cash_flow (annual, 2025-03-31) — End Cash Position: 1351494.00
CMET.L cash_flow (annual, 2025-03-31) — Financing Cash Flow: 0.00
CMET.L cash_flow (annual, 2025-03-31) — Free Cash Flow: -1844859.00
CMET.L income_statement (annual, 2025-03-31) — General And Administrative Expense: 702605.00
CMET.L balance_sheet (annual, 2025-03-31) — Gross PPE: 90684.00
CMET.L balance_sheet (quarterly, 2025-03-31) — Gross PPE: 90684.00
CMET.L income_statement (annual, 2025-03-31) — Gross Profit: -3773.00
CMET.L income_statement (annual, 2025-03-31) — Interest Income: 30158.00
CMET.L income_statement (annual, 2025-03-31) — Interest Income Non Operating: 30158.00
CMET.L cash_flow (annual, 2025-03-31) — Interest Received Cfi: 30158.00
CMET.L balance_sheet (annual, 2025-03-31) — Invested Capital: 6291342.00
CMET.L balance_sheet (quarterly, 2025-03-31) — Invested Capital: 6291342.00
CMET.L cash_flow (annual, 2025-03-31) — Investing Cash Flow: -626652.00
CMET.L balance_sheet (annual, 2025-03-31) — Investmentsin Subsidiariesat Cost: 0.00
CMET.L balance_sheet (quarterly, 2025-03-31) — Investmentsin Subsidiariesat Cost: 0.00
CMET.L cash_flow (annual, 2025-03-31) — Issuance Of Capital Stock: 0.00
CMET.L balance_sheet (annual, 2025-03-31) — Long Term Equity Investment: 0.00
CMET.L balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 0.00
CMET.L balance_sheet (annual, 2025-03-31) — Minority Interest: -119898.00
CMET.L balance_sheet (quarterly, 2025-03-31) — Minority Interest: -119898.00
CMET.L cash_flow (annual, 2025-03-31) — Net Common Stock Issuance: 0.00
CMET.L cash_flow (annual, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: -27562.00
CMET.L income_statement (annual, 2025-03-31) — Net Income: -1140932.00
CMET.L income_statement (annual, 2025-03-31) — Net Income Common Stockholders: -1140932.00
CMET.L income_statement (annual, 2025-03-31) — Net Income Continuous Operations: -1140932.00
CMET.L income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -1140932.00
CMET.L income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -1140932.00
CMET.L cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: -1140932.00
CMET.L income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: -1140932.00
CMET.L income_statement (annual, 2025-03-31) — Net Interest Income: 30158.00
CMET.L income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: 30158.00
CMET.L balance_sheet (annual, 2025-03-31) — Net PPE: 6078317.00
CMET.L balance_sheet (quarterly, 2025-03-31) — Net PPE: 6078317.00
CMET.L cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -656810.00
CMET.L balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 6291342.00
CMET.L balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 6291342.00
CMET.L income_statement (annual, 2025-03-31) — Normalized EBITDA: -979028.00
CMET.L income_statement (annual, 2025-03-31) — Normalized Income: -1115418.00
CMET.L cash_flow (annual, 2025-03-31) — Operating Cash Flow: -1186572.00
CMET.L income_statement (annual, 2025-03-31) — Operating Income: -1011088.00
CMET.L income_statement (annual, 2025-03-31) — Operating Revenue: 0.00
CMET.L balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 344806209.00
CMET.L balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 344806209.00
CMET.L balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 593750.00
CMET.L balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 593750.00
CMET.L balance_sheet (annual, 2025-03-31) — Other Equity Interest: 8115246.00
CMET.L balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 8115246.00
CMET.L cash_flow (annual, 2025-03-31) — Other Non Cash Items: -30158.00
CMET.L balance_sheet (annual, 2025-03-31) — Other Non Current Liabilities: 600000.00
CMET.L balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 600000.00
CMET.L income_statement (annual, 2025-03-31) — Other Operating Expenses: 49.00
CMET.L balance_sheet (annual, 2025-03-31) — Other Receivables: 9801.00
CMET.L balance_sheet (quarterly, 2025-03-31) — Other Receivables: 9801.00
CMET.L income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
CMET.L balance_sheet (annual, 2025-03-31) — Payables: 168470.00
CMET.L balance_sheet (quarterly, 2025-03-31) — Payables: 168470.00
CMET.L balance_sheet (annual, 2025-03-31) — Prepaid Assets: 44708.00
CMET.L balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 44708.00
CMET.L income_statement (annual, 2025-03-31) — Pretax Income: -1140932.00
CMET.L cash_flow (annual, 2025-03-31) — Purchase Of PPE: -658287.00
CMET.L income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 3773.00
CMET.L income_statement (annual, 2025-03-31) — Reconciled Depreciation: 6546.00
CMET.L balance_sheet (annual, 2025-03-31) — Restricted Cash: 3817.00
CMET.L balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 3817.00
CMET.L income_statement (annual, 2025-03-31) — Restructuring And Mergern Acquisition: 25514.00
CMET.L balance_sheet (annual, 2025-03-31) — Retained Earnings: -16192907.00
CMET.L balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -16192907.00
CMET.L cash_flow (annual, 2025-03-31) — Sale Of PPE: 1477.00
CMET.L income_statement (annual, 2025-03-31) — Selling General And Administration: 702605.00
CMET.L balance_sheet (annual, 2025-03-31) — Share Issued: 344806209.00
CMET.L balance_sheet (quarterly, 2025-03-31) — Share Issued: 344806209.00
CMET.L income_statement (annual, 2025-03-31) — Special Income Charges: -25514.00
CMET.L cash_flow (annual, 2025-03-31) — Stock Based Compensation: 4611.00
CMET.L balance_sheet (annual, 2025-03-31) — Stockholders Equity: 6291342.00
CMET.L balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 6291342.00
CMET.L balance_sheet (annual, 2025-03-31) — Tangible Book Value: 6291342.00
CMET.L balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 6291342.00
CMET.L income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
CMET.L income_statement (annual, 2025-03-31) — Tax Provision: 0.00
CMET.L income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.00
CMET.L balance_sheet (annual, 2025-03-31) — Taxes Receivable: 26222.00
CMET.L balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 26222.00
CMET.L balance_sheet (annual, 2025-03-31) — Total Assets: 7655402.00
CMET.L balance_sheet (quarterly, 2025-03-31) — Total Assets: 7655402.00
CMET.L balance_sheet (annual, 2025-03-31) — Total Capitalization: 6291342.00
CMET.L balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 6291342.00
CMET.L balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 6171444.00
CMET.L balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 6171444.00
CMET.L income_statement (annual, 2025-03-31) — Total Expenses: 1011088.00
CMET.L balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 1483958.00
CMET.L balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 1483958.00
CMET.L balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 6223177.00
CMET.L balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 6223177.00
CMET.L balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 600000.00
CMET.L balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 600000.00
CMET.L income_statement (annual, 2025-03-31) — Total Operating Income As Reported: -1171090.00
CMET.L balance_sheet (annual, 2025-03-31) — Total Tax Payable: 8569.00
CMET.L balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 8569.00
CMET.L income_statement (annual, 2025-03-31) — Total Unusual Items: -25514.00
CMET.L income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: -25514.00
CMET.L balance_sheet (annual, 2025-03-31) — Working Capital: 548267.00
CMET.L balance_sheet (quarterly, 2025-03-31) — Working Capital: 548267.00
CMET.L balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 637058.00
CMET.L balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 100853.00
CMET.L balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 59651917.00
CMET.L balance_sheet (quarterly, 2025-09-30) — Capital Stock: 6851056.00